# Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)

Study · id `cardio:ct-nct04041167` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04041167](<https://clinicaltrials.gov/study/NCT04041167>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04041167

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04041167. Randomized; no masking; primary purpose treatment. Start 2018-08-01 (actual); primary completion 2021-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04041167, source copy `cardio:ctgov-nct04041167-2019-08-02`, retrieved 2026-10-26)
- Started: 2018-08-01 (actual) (ClinicalTrials.gov record NCT04041167, source copy `cardio:ctgov-nct04041167-2019-08-02`, retrieved 2026-10-26)
- Primary completion: 2021-07-31 (anticipated) (ClinicalTrials.gov record NCT04041167, source copy `cardio:ctgov-nct04041167-2019-08-02`, retrieved 2026-10-26)
- Completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT04041167, source copy `cardio:ctgov-nct04041167-2019-08-02`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04041167, source copy `cardio:ctgov-nct04041167-2019-08-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04041167-2019-08-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)
- Condition: Stroke, Ischemic
- Intervention (Drug): alpha lipoic acid
- Intervention (Drug): Saline
- Lead sponsor: Chonnam National University Hospital
- Lead sponsor class: OTHER
- Collaborator: Chosun University Hospital
- Collaborator class: OTHER
- Collaborator: Chonbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Wonkwang University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Chonnam National University Hospital (`cardio:org-chonnam-national-university-hospital`)
- Registry lists this organization as a collaborator: Chosun University Hospital (`cardio:org-chosun-university-hospital`)
- Registry lists this organization as a collaborator: Chonbuk National University Hospital (`cardio:org-chonbuk-national-university-hospital`)
- Registry lists this organization as a collaborator: Wonkwang University Hospital (`cardio:org-wonkwang-university-hospital`)

## Provenance

Content hash: a39e19e0f14e0b7bc9a665905a3920880e81d55397b6a0eb19e1f0a40e38d733
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
